Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

DLK1 promoted ischemic angiogenesis through notch1 signaling in endothelial progenitor cells

Abstract

Delta like non-canonical Notch ligand 1 (DLK1), as a member of epidermal growth factor-like family, plays a critical role in somatic growth, tissue development and possibly tissue renewal. Though previous studies had indicated that DLK1 contributed to adipogenesis and myogenesis, it’s still controversial whether DLK1 affects angiogenesis and how it interacts with Notch signaling with numerous conflicting reports from different models. Based on our preliminary finding that DLK1 expression was up-regulated in mice ischemic gastrocnemius and in the border zone of infarcted myocardium, we administered either recombinant DLK1 (rDLK1) or PBS in C57BL/6 mice after establishment of hindlimb ischemia (HLI) and myocardial infarction (MI), respectively. Exogenous rDLK1 administration significantly improved both blood perfusion of mice ischemic hindlimbs and muscle motor function on the 3rd, 7th day after HLI, by promoting neovascularization. Similar effect on neovascularization was verified in mice on the 28th day after MI as well as improvement of cardiac failure. Correspondingly, the number of CD34+KDR+ cells, indicated as endothelial progenitor cells (EPCs), was significantly in mice ischemic gastrocnemius by rDLK1 administration, which was abrogated by DAPT as the specific inhibitor of Notch intracellular domain (NICD). Furthermore, bone marrow mononuclear cells were obtained from C57BL/6 mice and differentiated to EPCs ex vivo. Incubation with rDLK1 triggered Notch1 mRNA and NICD protein expressions in EPCs as exposed to hypoxia and serum deprivation, promoting EPCs proliferation, migration, anti-apoptosis and tube formation. Otherwise, rDLK1 incubation significantly decreased intracellular and mitochondrial reactive oxygen species, increased ATP content and mitochondrial membrane potential, downregulated short isoform of OPA-1 expression whereas upregulated mitofusin (-1, -2) expression in EPCs by Notch1 signaling, which were all abrogated by DAPT. In summary, the present study unveils the pro-angiogenesis and its mechanism of rDLK1 through activation of Notch1 signaling in endothelial progenitor cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Administration of exogenous rDLK1 promoted hindlimb perfusion recovery and neovascularization in HLI mice.
Fig. 2: Administration of exogenous rDLK1 triggered EPCs mobilization and infiltration into ischemic gastrocnemius.
Fig. 3: Perfusion recovery and neovascularization by exogenous rDLK1 were dependent on Notch1 signaling.
Fig. 4: Notch1 signaling was involved in mobilization and recruitment of EPCs by rDLK1.
Fig. 5: Administration of exogenous rDLK1 improved post-MI cardiac function by Notch1 signaling-dependent neovascularization.
Fig. 6: Exogenous rDLK1 altered biological functions of EPCs by Notch1 signaling.
Fig. 7: Exogenous rDLK1 affected mitochondria function and dynamics of EPCs by Notch1 signaling.
Fig. 8: Schematic diagram of the role and underlying mechanism of DLK1 in ischemic injury.

Similar content being viewed by others

Data availability

All data and material during the current study are available from the corresponding author on reasonable request.

References

  1. Floridon C, Jensen CH, Thorsen P, Nielsen O, Sunde L, Westergaard JG, et al. Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation. 2000;66:49–59.

    Article  CAS  PubMed  Google Scholar 

  2. Rammah M, Theveniau-Ruissy M, Sturny R, Rochais F, Kelly RG. PPARgamma and NOTCH regulate regional identity in the murine cardiac outflow tract. Circ Res. 2022;131:842–58.

    Article  CAS  PubMed  Google Scholar 

  3. da Silva C, Durandt C, Kallmeyer K, Ambele MA, Pepper MS. The Role of Pref-1 during adipogenic differentiation: an overview of suggested mechanisms. Int J Mol Sci. 2020;21:4104.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Shin S, Suh Y, Zerby HN, Lee K. Membrane-bound delta-like 1 homolog (Dlk1) promotes while soluble Dlk1 inhibits myogenesis in C2C12 cells. FEBS Lett. 2014;588:1100–8.

    Article  CAS  PubMed  Google Scholar 

  5. Pittaway JFH, Lipsos C, Mariniello K, Guasti L. The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer. Endocr Relat Cancer. 2021;28:R271–R87.

    Article  CAS  PubMed  Google Scholar 

  6. Huang CC, Kuo HM, Wu PC, Cheng SH, Chang TT, Chang YC, et al. Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1/Akt/eNOS signaling in endothelial cells. Angiogenesis. 2018;21:299–312.

    Article  CAS  PubMed  Google Scholar 

  7. Huang J, Zhao X, Wang J, Cheng Y, Wu Q, Wang B, et al. Distinct roles of Dlk1 isoforms in bi-potential differentiation of hepatic stem cells. Stem Cell Res Ther. 2019;10:31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ, et al. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol. 2002;22:5585–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Mohamadi MH, Rai A, Rezaei M, Khatony A. Lack of association between interarm systolic blood pressure difference and coronary artery disease in patients undergoing elective coronary angiography. Int J Hypertens. 2021;2021:6665039.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res. 2021;128:1818–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Samura M, Hosoyama T, Takeuchi Y, Ueno K, Morikage N, Hamano K. Therapeutic strategies for cell-based neovascularization in critical limb ischemia. J Transl Med. 2017;15:49.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lupu IE, De Val S, Smart N. Coronary vessel formation in development and disease: mechanisms and insights for therapy. Nat Rev Cardiol. 2020;17:790–806.

    Article  PubMed  Google Scholar 

  13. Dai X, Yan X, Zeng J, Chen J, Wang Y, Chen J, et al. Elevating CXCR7 improves angiogenic function of EPCs via Akt/GSK-3beta/Fyn-mediated Nrf2 activation in diabetic limb ischemia. Circ Res. 2017;120:e7–e23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kawamoto A, Asahara T, Losordo DW. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med. 2002;3:221–5.

    Article  PubMed  Google Scholar 

  15. Shao Y, Li X, Wood JW, Ma JX. Mitochondrial dysfunctions, endothelial progenitor cells and diabetic retinopathy. J Diabetes Compl. 2018;32:966–73.

    Article  Google Scholar 

  16. St Paul M, Ohashi PS. The roles of CD8+ T cell subsets in antitumor immunity. Trends Cell Biol. 2020;30:695–704.

    Article  Google Scholar 

  17. Mathiyalagan P, Liang Y, Kim D, Misener S, Thorne T, Kamide CE, et al. Angiogenic mechanisms of human CD34+ stem cell exosomes in the repair of ischemic hindlimb. Circ Res. 2017;120:1466–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Grassi ES, Pietras A. Emerging roles of DLK1 in the stem cell niche and cancer stemness. J Histochem Cytochem. 2022;70:17–28.

    Article  CAS  PubMed  Google Scholar 

  19. Chi Sabins N, Taylor JL, Fabian KP, Appleman LJ, Maranchie JK, Stolz DB, et al. DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature. Mol Ther. 2013;21:1958–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Huang CC, Cheng SH, Wu CH, Li WY, Wang JS, Kung ML, et al. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling. Oncogene. 2019;38:3201–15.

    Article  CAS  PubMed  Google Scholar 

  21. Rodriguez P, Higueras MA, Gonzalez-Rajal A, Alfranca A, Fierro-Fernandez M, Garcia-Fernandez RA, et al. The non-canonical NOTCH ligand DLK1 exhibits a novel vascular role as a strong inhibitor of angiogenesis. Cardiovasc Res. 2012;93:232–41.

    Article  CAS  PubMed  Google Scholar 

  22. Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014;20:368–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7.

    Article  CAS  PubMed  Google Scholar 

  24. Pysna A, Bem R, Nemcova A, Fejfarova V, Jirkovska A, Hazdrova J, et al. Endothelial progenitor cells biology in diabetes mellitus and peripheral arterial disease and their therapeutic potential. Stem Cell Rev Rep. 2019;15:157–65.

    Article  PubMed  Google Scholar 

  25. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449–57.

    Article  CAS  PubMed  Google Scholar 

  26. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiol (Bethesda). 2009;24:97–106.

    CAS  Google Scholar 

  27. Maeda S, Miyagawa S, Kawamura T, Shibuya T, Watanabe K, Nakagawa T, et al. Notch signaling-modified mesenchymal stem cells improve tissue perfusion by induction of arteriogenesis in a rat hindlimb ischemia model. Sci Rep. 2021;11:2543.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kachanova O, Lobov A, Malashicheva A. The role of the notch signaling pathway in recovery of cardiac function after myocardial infarction. Int J Mol Sci. 2022;23:12509.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Fu Y, Hao X, Shang P, Chamba Y, Zhang B, Zhang H. Functional identification of porcine DLK1 during muscle development. Anim (Basel). 2022;12:1523.

    Google Scholar 

  30. Liang T, Zhu L, Gao W, Gong M, Ren J, Yao H, et al. Coculture of endothelial progenitor cells and mesenchymal stem cells enhanced their proliferation and angiogenesis through PDGF and Notch signaling. FEBS Open Bio. 2017;7:1722–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kwon SM, Eguchi M, Wada M, Iwami Y, Hozumi K, Iwaguro H, et al. Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation. 2008;118:157–65.

    Article  PubMed  Google Scholar 

  32. Wang L, Wang YC, Hu XB, Zhang BF, Dou GR, He F, et al. Notch-RBP-J signaling regulates the mobilization and function of endothelial progenitor cells by dynamic modulation of CXCR4 expression in mice. PLoS One. 2009;4:e7572.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Huang D, Han Y, Tang T, Yang L, Jiang P, Qian W, et al. Dlk1 maintains adult mice long-term HSCs by activating Notch signaling to restrict mitochondrial metabolism. Exp Hematol Oncol. 2023;12:11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Begum A, Lin Q, Yu C, Kim Y, Yun Z. Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity. Mol Cancer Res. 2014;12:155–64.

    Article  CAS  PubMed  Google Scholar 

  35. Ito Y, Yamagata M, Yamamoto T, Hirasaka K, Nikawa T, Sato T. The reciprocal regulation between mitochondrial-associated membranes and Notch signaling in skeletal muscle atrophy. 2023;15;12:RP89381.

Download references

Acknowledgements

This study was supported by the National Natural Science Foundation of China (82270498) and National Health Commission, key program of science and technology of the Medical and Health of Zhejiang Province (WKJ-ZJ-2028).

Author information

Authors and Affiliations

Authors

Contributions

YYY and NZ conceived and designed the experiments. YYY, ZW and ZHY performed the experiments. YYY, QYB and SXL analyzed the data. YYY wrote the paper. XJX reviewed and revised the paper. All authors contributed to the article and approved the submitted version.

Corresponding author

Correspondence to Xiao-jie Xie.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

The use of clinical samples was approved by the Institutional Ethics Committee of Second Affiliated Hospital of Zhejiang University. All animal experiments were approved by Zhejiang University Institutional Animal Care and Use Committee (approval No. 2023-1969). All methods and experimental protocols were carried out in accordance with the guidelines and regulations of the Care and Use of Laboratory Animals of Zhejiang University.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

You, Yy., Zhang, N., Wang, Z. et al. DLK1 promoted ischemic angiogenesis through notch1 signaling in endothelial progenitor cells. Acta Pharmacol Sin (2024). https://doi.org/10.1038/s41401-024-01346-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41401-024-01346-0

Keywords

Search

Quick links